Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its June 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).
Chlamydia Urine - Positivity Index
Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In June 2024, all the rates converged at 1.4%, with the Total rate continuing to go up from 1.2% in May, the Female rate dropping from 1.5%, and the Male increasing from 0.9%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.
GC (Gonorrhea) Urine - Positivity Index
In June 2024, the Female rate is up again to 1.2% from 0.9%, the Total rate is also up to 0.7% from 0.5%, and the Male rate just turned upward to 0.3% from 0.2%. Looking at the trendline, this month's Female rate is moving over the trend while the other two remain within the trend.
Trichomonas Vaginalis Urine- Positivity Index
In June 2024 the Female rate turned up to 0.7% from 0.4%, the Total rate also went up to 0.4% from 0.3%, while the Male rate is at 0.0% from 0.2%. The current rate levels are still within the general range of 0.0% to 1.5%.
Mycoplasma Genitalium Urine - Positivity Index
In June 2024 two rates increased, the Total rate at 4.1% from 3.7% and the Female rate at 5.4% from 4.7%, while the Male rate just dropped to 2.6% from 2.7%.
Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index
Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In June 2024, the three Chlamydia Rectal rates decreased, the Total to 1.3% from 1.8%, the Female rate to 1.8% from 2.0%, and the Male rate to 0.7% from 1.7%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%, with the Male rate at 0.2% from 0.3%, the Total rate unchanged at 0.3%, and the Female rate also flat at 0.4%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swabrates, the Gonorrhea Rectal lines volatility, visible since April 2023, continues with the Total rate dropping to 0.7% from 1.1%, the Female rate still going up to 1.0% from 0.6%, and the Male rate dropping to 0.3% from 1.7%. The three Gonorrhea Throat rates remain within the range of the prior seven months, and in this month the Female rate decreased to 0.8% from 1.3%, the Male rate up to 1.0% from 0.8%, and the Total rate down to 0.9% from 1.1%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs show a more volatile behavior that then other three swab tests.
About Talent Testing Service, Inc. (TTS)
As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.
https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting